Page 13 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The global in vitro diagnostics market is expanding rapidly due to a surge in the number of diagnostic laboratories, rise in awareness regarding personalized medicine and early disease diagnosis, and growing prevalence of infectious and chronic diseases.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "In Vitro Diagnostics Market by Product and Services (Reagents and Kits, Instruments, Software, and Services), Technique, (Immunodiagnostic

Operator: Welcome everyone to Surmodics Fourth Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance November 8, 2023 07:00 a.m. ET ...

08.11.2023 - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2023, and introduced ...

Surmodics (NASDAQ:SRDX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, November 8th. Analysts expect Surmodics to post earnings of $0.16 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Surmodics Price Performance […]